Clinical Trial Update: CV004-007 Thrombosis Chamber Study [Phase 1]

View source ↗

Summary

Phase 1 study CV004-007 Thrombosis Chamber completed; an update from sponsor Bristol-Myers Squibb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis | Phase 1 | Status: COMPLETED